Pharmacy as the Front Line of the Consumer Experience Revolution
In an interview, Abarca President and COO Adriana Ramirez shared why the future of healthcare must prioritize the human experience, powered by technology.
presented by
presented by
MedCity Pivot Podcast: Price Transparency is the New North in the PBM World
In this episode, a pharmacy benefit management executive and a pharmacy startup talk about why benefit verification, prior authorizations, and patient affordability still break the workflow and how smart integrations, real-time eligibility, and intuitive design can reduce friction for all involved.
presented by
How (and Where) to Find the Best Value Rehabilitation Programs for Brain Injuries
Choosing the right brain injury rehabilitation program is a critical decision that can shape the future for you or your loved one.
How Pharma Marketers Can Prepare for Trump’s 200% Tariff Threat
Putting aside the politics of this situation for the moment, here are some ways for commercial execs to navigate the current climate of volatility.
Healthcare’s Data Orchestra: Why Rising Drug Denials Signal a Need for Better Coordination
The real story isn’t about denial rates or stakeholders acting as villains. It’s about a healthcare system that forces intelligent, well-intentioned professionals to make critical decisions in information silos.
Pharma Is Reclaiming Control Over Patient Experience. What Does It Mean For The Hub Model?
AI can now flag where patients are getting stuck — from enrollment delays to dropped calls — while also enabling new, compliant ways to analyze these interactions at scale. But surfacing the issue is just the first step.
From Urgent Care to Smarter Care: Using Rapid Testing to Fight Antibiotic Resistance
By making RT-PCR testing a routine option in outpatient and urgent care settings — and by educating all stakeholders along the clinical continuum — we can significantly reduce unnecessary antibiotic use, protect the effective drugs we still have, and ensure that bacterial infections remain treatable for future generations.
presented by
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
Bringing Clinical Data Management to the Cloud
Moving clinical data management to cloud platforms can carry myriad benefits for healthcare organizations.
Protecting Your Biotech: Understanding the Risks of Compounded GLP-1s
With the global market for anti-obesity drugs projected to hit $95 billion by 2030, it’s no surprise that compounded semaglutide is gaining traction as a cheaper, more accessible option. But for all its appeal, this route comes with real risks: regulatory uncertainty, legal exposure, and major insurance hurdles.
presented by
AI Is at the Heart of PBM Evolution
In an interview, Abarca Chief Information Officer Serge Perras discussed how Abarca is implementing AI and where he sees the most value for PBMs.
The Dysfunctional Drug Discount System’s Serious Implications on Patient Health
The current system is failing vulnerable patients – those it was designed to help. While well-intentioned, the savings these programs promise rarely trickle down to patients.
presented by
Discover the Most Effective Aquatic Therapy Programs in Chicago Suburbs
Incorporating aquatic therapy can enhance patient outcomes and shorten recovery times for health care professionals. In the Chicago suburbs, the demand for such programs is rising.
White Bagging: A Prescription for Disruption in Care
White bagging not only creates significant uncompensated administrative burden and scheduling challenges for providers, but it also delays or limits access to necessary medication for patients.
Creating a Specialty Pharmacy in a Space-Challenged Hospital Campus
Creating a specialty pharmacy in a space-challenged hospital campus can seem like a daunting task, particularly in a crowded metropolitan or suburban area. Here are some creative solutions to solve for this barrier.
GLP-1s, Personalization, and Big Pharma Power Plays: What’s Really at Stake in the Eli Lilly Lawsuit
This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.
When Cost Blocks Care: Why Medication Affordability Is the Next Frontier in Patient Care
Every day, patients are making agonizing choices to skip medications due to cost, and the fallout is evident in worsening health and avoidable hospitalizations. Health systems are in a prime position to break this cycle by acting as advocates for their patients’ financial as well as physical well-being.
From Hype to Impact: How Pharma Can Use Agentic AI to Drive Efficiency and Trust
Success with agentic AI won’t come from racing to adopt the flashiest tools. It will come from strategic alignment, understanding where AI can create real value, mitigating risk through thoughtful implementation, and ensuring transparency and oversight at every step.